Generic Medical Devices Establishes European Headquarters in Brussels

Generic Medical Devices, Inc.(TM) (GMD(TM)), the first company to
design, develop, manufacture and supply quality surgical products
marketed at generic prices, today announced that it has opened for
global business with the establishment of its European headquarters in
Brussels, Belgium. In addition, J.P. Allar has been named GMD's Vice
President, International Sales and Managing Director, GMD Europe, and
Daniel Verstappen, R.N. will join GMD as Senior Director, Clinical and
Regulatory, GMD Europe.

"We are thrilled to expand GMD's business opportunities into the
European market," said Richard Kuntz, president and CEO of Generic
Medical Devices. "Our goal is to bring quality, standard-of-care
devices to hospitals and physicians at a fraction of the current
market prices. The opening of our Brussels office will open the door
for business in Europe, which will allow us to begin bringing down
healthcare costs for EU-based healthcare facilities and systems where
physicians and administrators alike have often been the first to
embrace new initiatives that help them deliver the best care to as
many patients as possible. We are proud to have J.P. Allar and Daniel
Verstappen, two veterans of the medical device industry with extensive
experience in the European market, spearheading these efforts."

Together, Allar and Verstappen have almost 40 years of experience
in biotechnology in the European market. Before joining GMD, Allar
served for 10 years as the Managing Director and Director of Sales for
Cyberonics Europe. He also held various positions at Guidant
Corporation, Eli Lilly Benelux and Deckers Medical. Verstappen has
held various sales, marketing, clinical and regulatory positions at
Cyberonics Europe over the past nine years. Most recently, he served
as the Senior Director for the Clinical and Regulatory Department.

"The opportunity to help bring the revolutionary concept of
generic medical devices to the European market is one I couldn't pass
up," said Allar. "I believe my experiences with big device companies
will allow me to bring a keen focus to the launch of GMD's
international business."

"We want to be able to maintain high quality healthcare in
worldwide systems that are experiencing ever-increasing prices," said
Verstappen. "Introducing the generic model, which has helped reduce
costs so drastically in the pharmaceutical market, will hopefully
allow us to reduce device costs in a similar fashion--ultimately
providing services for more patients."

In January, GMD announced 510(k) clearance from the U.S. Food and
Drug Administration (FDA) and CE Marking to market its first product,
a circumcision clamp, domestically and internationally. In May, GMD
announced 510(k) clearance from the FDA of its first implantable
device, the GMD Universal Surgical Mesh. The Company has a pipeline of
additional products which are currently in the clinical review process
for CE Marking and 510(k) clearance.

GMD is the first company to implement the generic model, made
successful by the pharmaceuticals industry, within the medical device
market. Leveraging expired patents on standard-of-care surgical
devices that have undergone few, if any, changes since first being
introduced to the market, GMD is bringing high-quality, substantially
equivalent alternatives to market at lower prices. Devices chosen by
GMD all have existing 510(k) classification, reimbursement by Medicare
and third-party payors, established product safety, efficacy and
outcomes, and a trained surgeon/physician base.

About Generic Medical Devices

Generic Medical Devices, Inc.(TM) is the world's first designer,
developer, manufacturer and supplier of quality medical products
marketed at generic prices that allow healthcare providers to meet the
standard of care for patients. Recognizing the need for healthcare
reform and the ever-increasing burden that America's aging population
is placing on the healthcare system, GMD(TM) set out to develop
lower-priced products with proven outcomes and "better-than" product
features. These generic devices, based on products that are becoming a
commodity in the marketplace, allow the healthcare system to provide
more patients access to innovative and often expensive treatments
while helping to stem the tide of rising healthcare costs. The
company's quality system has been certified to meet the requirements
of ISO 13485:2003, providing a framework for global regulatory
compliance of its products. For general information, please visit
www.genericmedicaldevices.com.

Direct contact for J.P. Allar to jpallar@genericmedicaldevices.com

Direct contact for Daniel Verstappen to
dverstappen@genericmedicaldevices.com